BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33292133)

  • 1. Forkhead-box A3 (FOXA3) represses cancer stemness and partially potentiates chemosensitivity by targeting metastasis-associated in colon cancer 1 (MACC1) signaling pathway in colorectal cancer cells.
    Li N; Li Y; Gao H; Li J; Ma X; Liu X; Gong P; Cui X; Li Y
    Curr Cancer Drug Targets; 2020 Dec; ():. PubMed ID: 33292133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MACC1 Regulates LGR5 to Promote Cancer Stem Cell Properties in Colorectal Cancer.
    Erdem M; Lee KH; Hardt M; Regan JL; Kobelt D; Walther W; Mokrizkij M; Regenbrecht C; Stein U
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic Acid-Induced 2 (RAI2) Is a Novel Antagonist of Wnt/β-Catenin Signaling Pathway and Potential Biomarker of Chemosensitivity in Colorectal Cancer.
    Zhang W; Kong L; Zhu H; Sun D; Han Q; Yan B; Cui Z; Zhang W; Zhang S; Kang X; Dai G; Qian N; Yan W
    Front Oncol; 2022; 12():805290. PubMed ID: 35299743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
    Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
    Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MACC1 is post-transcriptionally regulated by miR-218 in colorectal cancer.
    Ilm K; Fuchs S; Mudduluru G; Stein U
    Oncotarget; 2016 Aug; 7(33):53443-53458. PubMed ID: 27462788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization.
    Feng WQ; Zhang YC; Gao H; Li WC; Miao YM; Xu ZF; Xu ZQ; Zhao JK; Zheng MH; Zong YP; Lu AG
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37203394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
    Wang G; Gu J; Gao Y
    Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
    Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N
    Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1.
    Kobelt D; Zhang C; Clayton-Lucey IA; Glauben R; Voss C; Siegmund B; Stein U
    Front Immunol; 2020; 11():980. PubMed ID: 32670264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
    Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
    Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_RNF13 Regulates the Stemness and Chemosensitivity of Colorectal Cancer by Transcriptional Regulation of DDX27 Mediated by TRIM24 Stabilization.
    Guo Y; Hu G; Tian B; Ma M; Long F; Chen M
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated forkhead-box A3 elevates the expression of forkhead-box A1 and forkhead-box A2 to promote metastasis in esophageal cancer.
    Chen B; Yu J; Lu L; Dong F; Zhou F; Tao X; Sun E
    Oncol Lett; 2019 May; 17(5):4351-4360. PubMed ID: 30944629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0006174 Accelerates Colorectal Cancer Progression Through Regulating miR-138-5p/MACC1 Axis.
    Wei J; Lin Y; Wang Z; Liu Y; Guo W
    Cancer Manag Res; 2021; 13():1673-1686. PubMed ID: 33628056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TWIST1 Promotes Colorectal Carcinoma Stemness and Oxaliplatin Resistance by Activating Microfibrillar-Associated Protein 2.
    Liu Y; Chen M; Wu B
    Assay Drug Dev Technol; 2023 Jul; 21(5):202-211. PubMed ID: 37428562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-338-3p suppresses colorectal cancer proliferation and progression by inhibiting MACC1.
    Zou T; Duan J; Liang J; Shi H; Zhen T; Li H; Zhang F; Dong Y; Han A
    Int J Clin Exp Pathol; 2018; 11(4):2256-2267. PubMed ID: 31938338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroartemisinin inhibited stem cell-like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT/mTOR signaling.
    Wang Y; Yang Z; Zhu W; Chen Y; He X; Li J; Han Z; Yang Y; Liu W; Zhang K
    Drug Dev Res; 2023 Aug; 84(5):988-998. PubMed ID: 37132439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
    Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
    J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.